(Q33404545)

26 July 2017

title

Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak (English)

1 reference

26 July 2017

0 references

J Menne

1

1 reference

26 July 2017

J T Kielstein

series ordinal

2

1 reference

26 July 2017

U Wenzel

series ordinal

3

1 reference

26 July 2017

R A K Stahl

series ordinal

4

1 reference

26 July 2017

language of work or name

German

0 references

publication date

1 December 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

53

1 reference

26 July 2017

issue

12

1 reference

26 July 2017

page(s)

1420-1430

1 reference

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Renal and neurological involvement in typical Shiga toxin-associated HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

"HUS diary" of a German nephrologist during the current EHEC outbreak in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Open-Source Genomic Analysis of Shiga-Toxin–Producing E. coli O104:H4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

A German outbreak of haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Immunoadsorption in patients with haemolytic uraemic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Immunoadsorption for paediatric post-diarrhoea haemolytic-uraemic syndrome with severe neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Eculizumab in severe Shiga-toxin-associated HUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

A nationwide case-control study of Escherichia coli O157:H7 infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00108-012-3107-5

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

21 January 2018

1 reference

12 December 2020

Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome

1 reference

12 December 2020

Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection

1 reference

12 December 2020

A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.

1 reference

12 December 2020

10.1007/S00108-012-3107-5

Identifiers

DOI

1 reference

release_zlc3srmvcnbulihhqi7popxr5e

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zlc3srmvcnbulihhqi7popxr5e

24 November 2022

mapped directly with Wikidata item

1 reference